AQR Capital Management
PHAT icon

AQR Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

AQR Capital Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$616K Buy
55,468
+1,020
+2% +$12.9K ﹤0.01% 3016
2025
Q4 		$903K Buy
54,448
+1,819
+3% +$26K ﹤0.01% 2613
2025
Q3 		$619K Buy
52,629
+2,705
+5% +$27.9K ﹤0.01% 2701
2025
Q2 		$479K Sell
49,924
-57,475
-54% -$318K ﹤0.01% 2634
2025
Q1 		$673K Buy
107,399
+89,741
+508% +$545K ﹤0.01% 2253
2024
Q4 		$143K Buy
+17,658
New +$219K ﹤0.01% 2722
2024
Q1 		– Sell
-18,427
Closed -$168K – 2481
2023
Q4 		$168K Sell
18,427
-4,408
-19% -$38K ﹤0.01% 2237
2023
Q3 		$237K Buy
+22,835
New +$313K ﹤0.01% 2089
2023
Q1 		– Sell
-10,046
Closed -$113K – 2233
2022
Q4 		$113K Buy
+10,046
New +$104K ﹤0.01% 2131

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return